Kevin Pelphrey is Harrison-Wood Professor of Neurology at the University of Virginia in Charlottesville.
Kevin Pelphrey
Harrison-Wood Professor of Neurology
University of Virginia
From this contributor
Why concern about facial recognition from brain scans is overblown
Can brain scans, in the wrong hands, compromise research participants' identity? The risk is minimal.
Why concern about facial recognition from brain scans is overblown
By
Kevin Pelphrey
18 February 2020 | 5 min read
What teenagers can teach scientists about autism
Examining the teenage years presents a major opportunity for understanding and treating autism.
What teenagers can teach scientists about autism
By
Kevin Pelphrey
27 February 2018 | 5 min read
Technology can curb social exclusion of children with autism
Apps, robots and brain imaging can help children with autism improve their social skills and connect with other people.
Technology can curb social exclusion of children with autism
By
Kevin Pelphrey
10 January 2017 | 6 min read
Reckless report exaggerates flaws in brain scan software
A bug in brain imaging software casts doubt on the results of some autism studies, but it’s way too soon to write off the powerful imaging technique.
Reckless report exaggerates flaws in brain scan software
By
Kevin Pelphrey
16 August 2016 | 6 min read
How dining out with my daughter inspired my autism studies
Restaurants can be stressful for my daughter Frances, who has autism, but her difficulties led me to try to better understand and treat her type of situational anxiety.
How dining out with my daughter inspired my autism studies
By
Kevin Pelphrey
12 May 2016 | 7 min read
Explore more from The Transmitter
Meet the Autism Data Science Initiative grantees
The awarded projects plan to study gene-and-environment interactions in people, stem cells and organoids, as well as predictors of positive life outcomes in autistic youth and adults.
Meet the Autism Data Science Initiative grantees
The awarded projects plan to study gene-and-environment interactions in people, stem cells and organoids, as well as predictors of positive life outcomes in autistic youth and adults.
By
Calli McMurray
3 October 2025 | 2 min read
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
By
Claudia López Lloreda
2 October 2025 | 6 min read
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
By
Calli McMurray
2 October 2025 | 10 min read